Loading…
Safer Drug Assessment Technology Advancement Act
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 3,722 other S bills in the 110th — cohort avg 42d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (5)
2007 · mid_year · Pharmacy
SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions
Bills with similar content found using semantic analysis.
Sources: Congress.gov
Client expense: Not reported · Firm income: $120,000
2007 · year_end · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008 H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, diabetes research funding S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language S. 2029, Physician Payments Sunshine Act of 2007 S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Client expense: Not reported · Firm income: $120,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
2007 · year_end · Pharmacy
H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2007 · year_end · Pharmacy
H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A, Division G) H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions H. R. 3093, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H.R. 3043, Labor, Heath/Human Services/Education/Related Agencies Appropriations Act, 2008 H.R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, drug safety provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor, Heath/Human Services/Education/Related Agencies Appropriations Act, 2008 S. 1745, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics
Client expense: Not reported · Firm income: $80,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2638, Homeland Security Appropriations Act, drug importation provisions H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A & G) H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials/drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
2007 · year_end · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics H. R. 2764, Foreign Operations and Related Programs Appropriations Act, 2008, (Division A & G) H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety H. R. 3043, Labor-HHS-Education and Related Agencies Appropriations Act, Medic H. R. 3580, Food and Drug Administration Amendments Act of 2007 S. 1024, Safer DATA Act, clinical trials and drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1710, Labor-HHS-Education and Related Agencies Appropriations Act, Medicare, healthcare, and drug pricing provisions S. 2029, Physician Payments Sunshine Act of 2007 S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
2007 · mid_year · Pharmacy
H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions S. 1745, Commerce, Justice, Science and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 623, Access to Life-Saving Medicine Act, follow-on biologics
Client expense: Not reported · Firm income: $100,000
2007 · mid_year · Medical/Disease Research/Clinical Labs
Biomedical Research Controlled Substances and Lit I Registration and Reregistration Fees Conventional Foods Being Marketed as "Functional Foods" Stem Cell Research S. 771 - Child Nutrition Promotion and School Lunch Protection Act of 2007 S. 1024 - Safer Drug Assessment Technology Advancement (Safer DATA) Act S. 1082 - Prescription Drug User Fee Amendments of 2007 4th Generation Cephalosporins in Humans
Client expense: $10,332,000 · Firm income: Not reported
2007 · mid_year · Pharmacy
S. 1644, Homeland Security Appropriations Act, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safer DATA Act, clinical trials and drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA and drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions
Client expense: Not reported · Firm income: $100,000
2007 · mid_year · Pharmacy
S. 4, Improving America's Security Act of 2007, cargo-screening provision S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. Con. Res. 99, Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation and comparative effectiveness provisions H. R. 1, Implementing the 9/11 Commission Recommendations Act of 2007, cargo-screening provision
Client expense: Not reported · Firm income: $80,000
2007 · mid_year · Pharmacy
H. R. 2606, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H. R. 2900, Food and Drug Administration Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate), Medicare cuts to finance SCHIP expansion H. R. 3162, CHAMP Act, Medicare cuts to finance SCHIP expansion S. 1376, 340B Program Improvement and Integrity Act of 2007, 340 B drug price expansion
Client expense: Not reported · Firm income: $120,000
2007 · mid_year · Pharmacy
H. R. 3093, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2642, Military Construction-VA and related Agencies Appropriations Act, diabetes care provisions S. 1645, Military Construction-VA and related Agencies Appropriations Act, diabetes care provisions H. Con. Res. 99, Budget Resolution, drug importation provisions S. Con. Res. 21, Budget Resolution, drug importation provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, drug safety provisions H. R. 2900, Food and Drug Administration Revitalization Act, drug safety provisions S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745, Departments of Commerce and Justice, Science, and Related Agencies Appropriations Act, DEA drug importation language H. R. 2638, Homeland Security Appropriations Act, drug importation provisions S. 1644, Homeland Security Appropriations Act, drug importation provisions
2007 · mid_year · Pharmacy
S. 1644 Homeland Security Appropriations Act, drug importion provisions H.Con Res. 99 Budget Resolution, drug importation and comparative effectiveness provisions S. Con. Res 21 Budget Resolution, drug imporatation and comparative effectiveness provisions S. 467, FACT Act, clinical trials and drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials and drug safety provisions S. 484, Enhancing Drug safety and Innovation Act of 2007, clinical trials and drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials and drug safety provisions S. 1024, Safe DATA Act, clinical trials and drug safety provisions HR 1561, Enhancing Drug safety and Innovation Act of 2007, PDUFA and Drug Safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA and drug safety HR 2900, Food and Drug Administration Amendments Act of 2007, PDUFA and drug safety S. 623, Access to Life-Saving Medicine Act, Follow-on Biologics HR 1038, Access to Life Saving Medicine Act, follow-on Biologics HR 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, Follow-on Biologics S. 1505, Affordable Biologics for Consumers Act of 2007, Follow-on Biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, Follow-on Biologics S. 1156, Best Pharmaceuticals for Children Amendments of 2007, pediatric exclusivity provisions in FDARA / PDUFA Bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions S. 1745 Commerce, Justice, Science, and Related Agencies Appropriations Act, DEA Drug importation language HR 2638, Homeland Security Appropriations Act, Drug Importation Provisions Product approval discussions with Deputy Director, Food and Drug Administration
Client expense: $920,000 · Firm income: Not reported
2007 · mid_year · Pharmacy
S. 623, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H.R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biolgoics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics H.R. 1561, Enhancing Drug Safety and Innovaction Act of 2007, PDUFA, drug safety provisions S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA, drug safety provisions H.R. 2900, Food and Drug Administratio Amendments Act of 2007, PDUFA, drug safety provisions S. 467, FACT Act, clinical trials/drug safety provisions S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. Con. Res. 99, Budget Resolution, drug importation, comparative effectiveness provisions S. Con. Res. 21, Budget Resolution, drug importation, comparative effectiveness provisions SCHIP (Senate); Medicare cuts to finance SCHIP expansion H.R. 3162; CHAMP Act; Medicare cuts to finance SCHIP expansion S. 1376; 340B Program Improvement and Integrity Act of 2007, 340 B Drug Price Expansion H.R. 2606, 340B Proram Improvement and Intergrity Act of 2007, 340 B Drug Price Expansion
Client expense: $941,000 · Firm income: Not reported
2007 · mid_year · Pharmacy
S. 596, Safe Internet Pharmacy Act of 2007, clinical trials/drug safety provisions S. 484, Enhancing Drug Safety and Innovation Act of 2007, clinical trials/drug safety provisions S. 993, Pediatric Research Improvement Act, clinical trials/drug safety provisions S. 1024, Safer DATA Act, clinical trials/drug safety provisions H. R. 1561, Enhancing Drug Safety and Innovation Act of 2007, PDUFA/drug safety S. 1082, Prescription Drug User Fee Amendments of 2007, PDUFA/drug safety H. R. 2900, Food and Drug Administration Revitalization Act, PDUFA/drug safety S. 623, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1038, Access to Life-Saving Medicine Act, follow-on biologics H. R. 1956, Patient Protection and Innovative Biologic Medicines Act of 2007, follow-on biologics S. 1505, Affordable Biologics for Consumers Act of 2007, follow-on biologics S. 1695, Biologics Price Competition and Innovation Act of 2007, follow-on biologics S. 1156, Best Pharmaceuticals for Children Amendmentsk, pediatric exclusivity provisions in FDARA/PDUFA bill S. 242, Pharmaceutical Market Access and Drug Safety Act of 2007, drug importation provisions H. R. 1585, National Defense Authorization Act, drug pricing provisions S. 1547, National Defense Authorization Act, drug pricing provisions S. 467, FACT Act, clinical trials/drug safety provisions
Client expense: Not reported · Firm income: $40,000
2007 · mid_year · Consumer Issues/Safety/Products
Data Accountability and Trust Act - HR 958 Personal Data Privacy and Security Act of 2007 - S 495 Safer DATA Act - S.1024 General Privacy Issues Data Security Act of 2007- HR 1685 Data Security Act of 2007 - S. 1260
Client expense: Not reported · Firm income: $40,000
Government targets: Federal Trade Commission (FTC), HOUSE OF REPRESENTATIVES, SENATE
Client expense: Not reported · Firm income: $100,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Natl Institutes of Health (NIH), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Client expense: Not reported · Firm income: $40,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Patent & Trademark Office (PTO), SENATE
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE